Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

VANCOUVER, British Columbia, Jan. 07, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced that the company has engaged JBN Partners, LLC (“JBN”) to increase public awareness of and interest in...

Source

Article Link: Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services - Psilocybin Alpha